GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK)

 MAPK5_HUMAN             Reviewed;         473 AA.
Q8IW41; B3KVA5; O60491; Q86X46; Q9BVX9; Q9UG86;
13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
13-SEP-2004, sequence version 2.
17-JUN-2020, entry version 172.
RecName: Full=MAP kinase-activated protein kinase 5;
Short=MAPK-activated protein kinase 5;
Short=MAPKAP kinase 5;
Short=MAPKAP-K5;
Short=MAPKAPK-5;
Short=MK-5;
Short=MK5;
EC=2.7.11.1;
AltName: Full=p38-regulated/activated protein kinase;
Short=PRAK;
Name=MAPKAPK5; Synonyms=PRAK;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), MUTAGENESIS OF THR-182,
FUNCTION, TISSUE SPECIFICITY, PHOSPHORYLATION AT THR-182, AND ACTIVITY
REGULATION.
TISSUE=Placenta;
PubMed=9628874; DOI=10.1093/emboj/17.12.3372;
New L., Jiang Y., Zhao M., Liu K., Zhu W., Flood L.J., Kato Y.,
Parry G.C.N., Han J.;
"PRAK, a novel protein kinase regulated by the p38 MAP kinase.";
EMBO J. 17:3372-3384(1998).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
Hunkapiller M.W., Myers E.W., Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Cervix, Pancreas, and Placenta;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project:
the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 133-473 (ISOFORM 2).
TISSUE=Brain;
PubMed=17974005; DOI=10.1186/1471-2164-8-399;
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[6]
INTERACTION WITH SQSTM1, ACTIVITY REGULATION, AND SUBCELLULAR LOCATION.
PubMed=10708586; DOI=10.1006/bbrc.2000.2333;
Sudo T., Maruyama M., Osada H.;
"p62 functions as a p38 MAP kinase regulator.";
Biochem. Biophys. Res. Commun. 269:521-525(2000).
[7]
SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-212, MUTAGENESIS OF THR-182,
AND MUTAGENESIS OF LYS-51; THR-182 AND SER-212.
PubMed=12808055; DOI=10.1091/mbc.e02-08-0538;
New L., Jiang Y., Han J.;
"Regulation of PRAK subcellular location by p38 MAP kinases.";
Mol. Biol. Cell 14:2603-2616(2003).
[8]
FUNCTION IN PHOSPHORYLATION OF HSPB1, AND INTERACTION WITH YWHAE.
PubMed=17728103; DOI=10.1016/j.cellsig.2007.07.016;
Tak H., Jang E., Kim S.B., Park J., Suk J., Yoon Y.S., Ahn J.K., Lee J.H.,
Joe C.O.;
"14-3-3epsilon inhibits MK5-mediated cell migration by disrupting F-actin
polymerization.";
Cell. Signal. 19:2379-2387(2007).
[9]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[10]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19413330; DOI=10.1021/ac9004309;
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
"Lys-N and trypsin cover complementary parts of the phosphoproteome in a
refined SCX-based approach.";
Anal. Chem. 81:4493-4501(2009).
[11]
FUNCTION IN PHOSPHORYLATION OF HSPB1.
PubMed=19166925; DOI=10.1016/j.cellsig.2009.01.009;
Kostenko S., Johannessen M., Moens U.;
"PKA-induced F-actin rearrangement requires phosphorylation of Hsp27 by the
MAPKAP kinase MK5.";
Cell. Signal. 21:712-718(2009).
[12]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-182, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Leukemic T-cell;
PubMed=19690332; DOI=10.1126/scisignal.2000007;
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
Rodionov V., Han D.K.;
"Quantitative phosphoproteomic analysis of T cell receptor signaling
reveals system-wide modulation of protein-protein interactions.";
Sci. Signal. 2:RA46-RA46(2009).
[13]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-182 AND SER-354, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[14]
VARIANTS [LARGE SCALE ANALYSIS] ILE-67 AND LYS-282.
PubMed=17344846; DOI=10.1038/nature05610;
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
Futreal P.A., Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
[15]
FUNCTION IN PHOSPHORYLATION OF TP53.
PubMed=17254968; DOI=10.1016/j.cell.2006.11.050;
Sun P., Yoshizuka N., New L., Moser B.A., Li Y., Liao R., Xie C., Chen J.,
Deng Q., Yamout M., Dong M.Q., Frangou C.G., Yates J.R. III, Wright P.E.,
Han J.;
"PRAK is essential for ras-induced senescence and tumor suppression.";
Cell 128:295-308(2007).
[16]
FUNCTION IN PHOSPHORYLATION OF FOXO3, AUTOPHOSPHORYLATION, INDUCTION, AND
MUTAGENESIS OF THR-182 AND LEU-337.
PubMed=21329882; DOI=10.1016/j.molcel.2011.01.023;
Kress T.R., Cannell I.G., Brenkman A.B., Samans B., Gaestel M., Roepman P.,
Burgering B.M., Bushell M., Rosenwald A., Eilers M.;
"The MK5/PRAK kinase and Myc form a negative feedback loop that is
disrupted during colorectal tumorigenesis.";
Mol. Cell 41:445-457(2011).
[17]
REVIEW.
PubMed=20227494; DOI=10.1016/j.cellsig.2010.03.002;
Shiryaev A., Moens U.;
"Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: menage a trois
or menage a quatre?";
Cell. Signal. 22:1185-1192(2010).
-!- FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in
mTORC1 signaling and post-transcriptional regulation. Phosphorylates
FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as
a tumor suppressor by mediating Ras-induced senescence and
phosphorylating p53/TP53. Involved in post-transcriptional regulation
of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3
leads to promote nuclear localization of FOXO3, enabling expression of
miR-34b and miR-34c, 2 post-transcriptional regulators of MYC that bind
to the 3'UTR of MYC transcript and prevent MYC translation. Acts as a
negative regulator of mTORC1 signaling by mediating phosphorylation and
inhibition of RHEB. Part of the atypical MAPK signaling via its
interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the
complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, but the
complex follows a complex set of phosphorylation events: upon
interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6
(or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and
activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or
ERK4/MAPK4). Mediates phosphorylation of HSP27/HSPB1 in response to
PKA/PRKACA stimulation, inducing F-actin rearrangement.
{ECO:0000269|PubMed:17254968, ECO:0000269|PubMed:17728103,
ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:21329882,
ECO:0000269|PubMed:9628874}.
-!- CATALYTIC ACTIVITY:
Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
-!- CATALYTIC ACTIVITY:
Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
EC=2.7.11.1;
-!- ACTIVITY REGULATION: Activated following phosphorylation at Thr-182 by
p38-alpha/MAPK14, p38-beta/MAPK11, ERK2/MAPK1, ERK3/MAPK6, and
ERK4/MAPK4. Activated by stress-related extracellular stimuli; such as
H(2)O(2), arsenite, anisomycin TNF alpha and also PMA and the calcium
ionophore A23187; but to a lesser extent. In vitro, activated by
SQSTM1. Inhibited by diterpenoid alkaloid noroxoaconitine.
{ECO:0000269|PubMed:10708586, ECO:0000269|PubMed:9628874}.
-!- SUBUNIT: Interacts with ERK3/MAPK6 and ERK4/MAPK4 (via FRIEDE motif);
the interaction is direct (By similarity). Interacts with YWHAE; the
interaction prevents phosphorylation of HSP27/HSPB1 leading to disrupt
F-actin polymerization. Interacts with SQSTM1. {ECO:0000250,
ECO:0000269|PubMed:10708586, ECO:0000269|PubMed:17728103}.
-!- INTERACTION:
Q8IW41; Q15109: AGER; NbExp=6; IntAct=EBI-1201460, EBI-1646426;
Q8IW41; P04792: HSPB1; NbExp=2; IntAct=EBI-1201460, EBI-352682;
Q8IW41; Q16659: MAPK6; NbExp=7; IntAct=EBI-1201460, EBI-1384105;
Q8IW41; P04637: TP53; NbExp=2; IntAct=EBI-1201460, EBI-366083;
Q8IW41-2; Q16659: MAPK6; NbExp=6; IntAct=EBI-11958803, EBI-1384105;
-!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Translocates to the
cytoplasm following phosphorylation and activation. Interaction with
ERK3/MAPK6 or ERK4/MAPK4 and phosphorylation at Thr-182, activates the
protein kinase activity, followed by translocation to the cytoplasm.
Phosphorylation by PKA/PRKACA at Ser-115 also induces nuclear export.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q8IW41-1; Sequence=Displayed;
Name=2;
IsoId=Q8IW41-2; Sequence=VSP_011597;
-!- TISSUE SPECIFICITY: Expressed ubiquitously.
{ECO:0000269|PubMed:9628874}.
-!- INDUCTION: Directly regulated by MYC: expression is activated by MYC,
suggesting the existence of a feedback regulatory loop.
{ECO:0000269|PubMed:21329882}.
-!- PTM: Phosphorylated on Thr-182 ERK3/MAPK6 or ERK4/MAPK4; which is the
regulatory phosphorylation site and is located on the T-loop/loop 12,
leading to activation. Phosphorylation at Thr-182 by p38-alpha/MAPK14,
p38-beta/MAPK11 is subject to debate. Phosphorylated at Ser-115 by
PKA/PRKACA, leading to localization to the cytoplasm.
Autophosphorylated (By similarity). {ECO:0000250}.
-!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
protein kinase family. {ECO:0000305}.
-!- CAUTION: The role of p38 MAPK kinases is unclear in phosphorylation and
activation of MAPKAPK5. According to some reports, it interacts and is
phosphorylated by p38-alpha/MAPK14 and p38-beta/MAPK11 (PubMed:9628874
and PubMed:12808055). According to other reports, it is not activated
by p38-alpha/MAPK14 and p38-beta/MAPK11. An explanation for these
discrepancies, might be that the interaction with p38 MAPK kinases is
weak and occurs only under specific conditions. {ECO:0000305}.
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; AF032437; AAC39863.1; -; Genomic_DNA.
EMBL; AK122767; BAG53717.1; -; mRNA.
EMBL; CH471054; EAW97981.1; -; Genomic_DNA.
EMBL; BC000833; AAH00833.1; -; mRNA.
EMBL; BC041049; AAH41049.1; -; mRNA.
EMBL; BC047284; AAH47284.2; -; mRNA.
EMBL; AL110301; CAB53747.1; -; mRNA.
CCDS; CCDS44975.1; -. [Q8IW41-1]
CCDS; CCDS44976.1; -. [Q8IW41-2]
PIR; T34519; T34519.
RefSeq; NP_003659.2; NM_003668.3. [Q8IW41-2]
RefSeq; NP_620777.1; NM_139078.2. [Q8IW41-1]
SMR; Q8IW41; -.
BioGRID; 114120; 24.
CORUM; Q8IW41; -.
IntAct; Q8IW41; 21.
MINT; Q8IW41; -.
STRING; 9606.ENSP00000449381; -.
BindingDB; Q8IW41; -.
ChEMBL; CHEMBL3094; -.
DrugBank; DB12010; Fostamatinib.
GuidetoPHARMACOLOGY; 2096; -.
iPTMnet; Q8IW41; -.
PhosphoSitePlus; Q8IW41; -.
BioMuta; MAPKAPK5; -.
DMDM; 52000829; -.
EPD; Q8IW41; -.
jPOST; Q8IW41; -.
MassIVE; Q8IW41; -.
MaxQB; Q8IW41; -.
PaxDb; Q8IW41; -.
PeptideAtlas; Q8IW41; -.
PRIDE; Q8IW41; -.
ProteomicsDB; 70805; -. [Q8IW41-1]
ProteomicsDB; 70806; -. [Q8IW41-2]
Antibodypedia; 3873; 596 antibodies.
DNASU; 8550; -.
Ensembl; ENST00000550735; ENSP00000449667; ENSG00000089022. [Q8IW41-2]
Ensembl; ENST00000551404; ENSP00000449381; ENSG00000089022. [Q8IW41-1]
GeneID; 8550; -.
KEGG; hsa:8550; -.
UCSC; uc001tta.5; human. [Q8IW41-1]
CTD; 8550; -.
DisGeNET; 8550; -.
EuPathDB; HostDB:ENSG00000089022.13; -.
GeneCards; MAPKAPK5; -.
HGNC; HGNC:6889; MAPKAPK5.
HPA; ENSG00000089022; Low tissue specificity.
MIM; 606723; gene.
neXtProt; NX_Q8IW41; -.
OpenTargets; ENSG00000089022; -.
PharmGKB; PA30633; -.
eggNOG; KOG0604; Eukaryota.
eggNOG; ENOG410XP8F; LUCA.
GeneTree; ENSGT00940000154089; -.
HOGENOM; CLU_000288_63_0_1; -.
InParanoid; Q8IW41; -.
KO; K04442; -.
OMA; GFFIHDP; -.
OrthoDB; 843707at2759; -.
PhylomeDB; Q8IW41; -.
TreeFam; TF312891; -.
Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
SignaLink; Q8IW41; -.
SIGNOR; Q8IW41; -.
BioGRID-ORCS; 8550; 12 hits in 817 CRISPR screens.
ChiTaRS; MAPKAPK5; human.
GeneWiki; MAPKAPK5; -.
GenomeRNAi; 8550; -.
Pharos; Q8IW41; Tchem.
PRO; PR:Q8IW41; -.
Proteomes; UP000005640; Chromosome 12.
RNAct; Q8IW41; protein.
Bgee; ENSG00000089022; Expressed in corpus callosum and 208 other tissues.
ExpressionAtlas; Q8IW41; baseline and differential.
Genevisible; Q8IW41; HS.
GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
GO; GO:0005829; C:cytosol; IDA:HPA.
GO; GO:0005654; C:nucleoplasm; IDA:HPA.
GO; GO:0005634; C:nucleus; IBA:GO_Central.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0009931; F:calcium-dependent protein serine/threonine kinase activity; IBA:GO_Central.
GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
GO; GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc.
GO; GO:0051019; F:mitogen-activated protein kinase binding; IBA:GO_Central.
GO; GO:0002039; F:p53 binding; IDA:UniProtKB.
GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
GO; GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB.
GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
GO; GO:0051973; P:positive regulation of telomerase activity; IMP:BHF-UCL.
GO; GO:1904355; P:positive regulation of telomere capping; IMP:BHF-UCL.
GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
GO; GO:0007265; P:Ras protein signal transduction; IDA:UniProtKB.
GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
GO; GO:0006417; P:regulation of translation; IDA:UniProtKB.
GO; GO:0007165; P:signal transduction; TAS:ProtInc.
GO; GO:0090400; P:stress-induced premature senescence; IDA:UniProtKB.
InterPro; IPR011009; Kinase-like_dom_sf.
InterPro; IPR000719; Prot_kinase_dom.
InterPro; IPR008271; Ser/Thr_kinase_AS.
Pfam; PF00069; Pkinase; 1.
SMART; SM00220; S_TKc; 1.
SUPFAM; SSF56112; SSF56112; 1.
PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
1: Evidence at protein level;
Alternative splicing; ATP-binding; Coiled coil; Cytoplasm; Kinase;
Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
Reference proteome; Serine/threonine-protein kinase; Transferase;
Tumor suppressor.
CHAIN 1..473
/note="MAP kinase-activated protein kinase 5"
/id="PRO_0000086296"
DOMAIN 22..304
/note="Protein kinase"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
NP_BIND 28..36
/note="ATP"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
COILED 409..440
/evidence="ECO:0000255"
ACT_SITE 148
/note="Proton acceptor"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
ECO:0000255|PROSITE-ProRule:PRU10027"
BINDING 51
/note="ATP"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
MOD_RES 115
/note="Phosphoserine; by PKA"
/evidence="ECO:0000250|UniProtKB:O54992"
MOD_RES 182
/note="Phosphothreonine; by MAPK11, MAPK14, MAPK4, MAPK6
and PKA"
/evidence="ECO:0000244|PubMed:19690332,
ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:9628874"
MOD_RES 212
/note="Phosphoserine"
/evidence="ECO:0000269|PubMed:12808055"
MOD_RES 354
/note="Phosphoserine"
/evidence="ECO:0000244|PubMed:23186163"
VAR_SEQ 407..408
/note="Missing (in isoform 2)"
/evidence="ECO:0000303|PubMed:14702039,
ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
/id="VSP_011597"
VARIANT 67
/note="M -> I (in dbSNP:rs34132040)"
/evidence="ECO:0000269|PubMed:17344846"
/id="VAR_040758"
VARIANT 282
/note="R -> K (in dbSNP:rs34843470)"
/evidence="ECO:0000269|PubMed:17344846"
/id="VAR_040759"
MUTAGEN 51
/note="K->M: Kinase defective mutant, abolishes activity."
/evidence="ECO:0000269|PubMed:12808055"
MUTAGEN 182
/note="T->A: No p38-beta/MAPK11-induced activation."
/evidence="ECO:0000269|PubMed:12808055,
ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874"
MUTAGEN 182
/note="T->D: Mimicks phosphorylation state and induces
constitutive protein kinase activity."
/evidence="ECO:0000269|PubMed:12808055,
ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874"
MUTAGEN 212
/note="S->D: Mimicks phosphorylation state and displays a
slightly higher protein kinase activity."
/evidence="ECO:0000269|PubMed:12808055"
MUTAGEN 337
/note="L->G: Induces constitutive protein kinase activity."
/evidence="ECO:0000269|PubMed:21329882"
CONFLICT 273
/note="I -> T (in Ref. 5; CAB53747)"
/evidence="ECO:0000305"
CONFLICT 291
/note="E -> R (in Ref. 1; AAC39863)"
/evidence="ECO:0000305"
SEQUENCE 473 AA; 54220 MW; F3D9DDC83CC0C49D CRC64;
MSEESDMDKA IKETSILEEY SINWTQKLGA GISGPVRVCV KKSTQERFAL KILLDRPKAR
NEVRLHMMCA THPNIVQIIE VFANSVQFPH ESSPRARLLI VMEMMEGGEL FHRISQHRHF
TEKQASQVTK QIALALRHCH LLNIAHRDLK PENLLFKDNS LDAPVKLCDF GFAKIDQGDL
MTPQFTPYYV APQVLEAQRR HQKEKSGIIP TSPTPYTYNK SCDLWSLGVI IYVMLCGYPP
FYSKHHSRTI PKDMRRKIMT GSFEFPEEEW SQISEMAKDV VRKLLKVKPE ERLTIEGVLD
HPWLNSTEAL DNVLPSAQLM MDKAVVAGIQ QAHAEQLANM RIQDLKVSLK PLHSVNNPIL
RKRKLLGTKP KDSVYIHDHE NGAEDSNVAL EKLRDVIAQC ILPQAGKGEN EDEKLNEVMQ
EAWKYNRECK LLRDTLQSFS WNGRGFTDKV DRLKLAEIVK QVIEEQTTSH ESQ


Related products :

Catalog number Product name Quantity
E1632h ELISA kit 3pK,Chromosome 3p kinase,Homo sapiens,Human,MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,MAPKAPK3,MAPKAPK-3 96T
E1632h ELISA 3pK,Chromosome 3p kinase,Homo sapiens,Human,MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,MAPKAPK3,MAPKAPK-3 96T
U1632h CLIA 3pK,Chromosome 3p kinase,Homo sapiens,Human,MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,MAPKAPK3,MAPKAPK-3 96T
32-205 PRAK (p38-regulated _activated kinase), also referred to as mitogen-activated protein kinase (MAPK)-activated protein kinase (MAPKAPK)-5, is an ubiquitously expressed serine_threonine kinase regulated 0.1 mL
E1632r ELISA MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,Mapkapk3,MAPKAPK-3,Rat,Rattus norvegicus 96T
E1632m ELISA MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,Mapkapk3,MAPKAPK-3,Mouse,Mus musculus 96T
U1632r CLIA MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,Mapkapk3,MAPKAPK-3,Rat,Rattus norvegicus 96T
E1632m ELISA kit MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,Mapkapk3,MAPKAPK-3,Mouse,Mus musculus 96T
E1632b ELISA Bos taurus,Bovine,MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,MAPKAPK3,MAPKAPK-3 96T
U1632m CLIA MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,Mapkapk3,MAPKAPK-3,Mouse,Mus musculus 96T
U1632b CLIA Bos taurus,Bovine,MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,MAPKAPK3,MAPKAPK-3 96T
E1632r ELISA kit MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,Mapkapk3,MAPKAPK-3,Rat,Rattus norvegicus 96T
E1632b ELISA kit Bos taurus,Bovine,MAP kinase-activated protein kinase 3,MAPK-activated protein kinase 3,MAPKAP kinase 3,MAPKAPK3,MAPKAPK-3 96T
15-288-22349B MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK Polyclonal 0.1 mg
15-288-22349B MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK Polyclonal 0.05 mg
15-288-22349A MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK Polyclonal 0.05 mg
15-288-22349A MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK Polyclonal 0.1 mg
10-782-55070 MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK N_A 0.05 mg
10-782-55070 MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK N_A 0.02 mg
10-782-55069 MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK N_A 0.02 mg
10-782-55069 MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK N_A 0.001 mg
10-288-22349F MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK 0.05 mg
10-288-22349F MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK 0.1 mg
10-782-55069 MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK N_A 0.005 mg
10-782-55069 MAP kinase-activated protein kinase 3 - EC 2.7.11.1; MAPK-activated protein kinase 3; MAPKAP kinase 3; MAPKAPK-3; Chromosome 3p kinase; 3pK N_A 0.01 mg